Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
Diabetes Care · 01.02.2025 · 48 (2) · 292-300
DOI: 10.2337/dc24-1678 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes Care, online erschienen am 22.01.2025. Verfasst von Hon Jen Wong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Waist Circumference, Weight Loss, Obesity, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 218-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Novartis.
Abstract (Originalsprache)
OBJECTIVE To provide an updated synthesis on effects of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on weight, BMI, and waist circumference incorporating newer randomized controlled trials (RCTs), particularly in individuals with overweight or obesity. RESEARCH DESIGN AND METHODS We systematically searched PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) for RCTs published from inception to 4 October 2024. The search was limited to RCTs evaluating the use of GLP-1 RAs for mean differences from baseline in weight, BMI, and waist circumference in adults with obesity or overweight with or without diabetes. Two independent reviewers performed the literature search and data extraction, resolving disagreements via consensus or third-reviewer consultation. RESULTS Forty-seven RCTs were included, with a combined cohort of 23,244 patients. GLP-1 RAs demonstrated a mean weight reduction of −4.57 kg (95% CI −5.35 to −3.78), mean BMI reduction of −2.07 kg/m2 (95% CI −2.53 to −1.62), and mean waist circumference reduction of −4.55 cm (95% CI −5.72 to −3.38) compared with placebo. This effect was consistent across diabetes status, GLP-1 RA used, and route of administration. The greatest treatment benefit appeared to favor patients who were younger, female, without diabetes, with higher baseline weight and BMI but lower baseline HbA1c, and treated over a longer duration. Limitations include substantial statistical heterogeneity, in part due to broad inclusion criteria. However, this heterogeneity may improve generalizability by reflecting a wide range of study designs and patient populations. CONCLUSIONS GLP-1 RAs demonstrated significant weight, BMI, and waist circumference reduction benefits in this meta-analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Department of Cardiology, National University Heart Centre Singapore, Singapore.
- Division of Neurology, Department of Medicine, National University Hospital, Singapore.
- Division of Endocrinology, Department of Medicine, National University Hospital, Singapore.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, U.K.
ORCID-Profile: Bryan Sim, Pei Chia Eng, Naveed Sattar
Förderung
- Novartis
Zitieren
APA
Wong, H. J., Sim, B., Teo, Y. H., Teo, Y. N., Chan, M. Y., Yeo, L. L. L., Eng, P. C., Tan, B. Y. Q., Sattar, N., Dalakoti, M., & Sia, C. H. (2025). Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care, 48(2), 292-300. https://doi.org/10.2337/dc24-1678
Vancouver
Wong HJ, Sim B, Teo YH, Teo YN, Chan MY, Yeo LLL, et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care. 2025;48(2):292-300. doi:10.2337/dc24-1678
BibTeX
@article{Wong2025,
author = {Wong, Hon Jen and Sim, Bryan and Teo, Yao Hao and Teo, Yao Neng and Chan, Mark Y and Yeo, Leonard L L and Eng, Pei Chia and Tan, Benjamin Y Q and Sattar, Naveed and Dalakoti, Mayank and Sia, Ching-Hui},
title = {Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials},
journal = {Diabetes Care},
year = {2025},
volume = {48},
number = {2},
pages = {292--300},
doi = {10.2337/dc24-1678}
}
EUVIMED